DNA Capital VC II LP Files SEC Notice Under Section 3(c)(7)

DNA Capital VC II LP submitted a filing to the U.S. Securities and Exchange Commission on May 18, 2026. The document, assigned accession number 0000905148-26-002508, lists the fund under CIK 0002123937 and carries a file size of 10 KB.

Filing Details

The submission references Item 3C and specifically Item 3C.7 under the Investment Company Act. It identifies the fund as D - DNA Capital VC II LP. The filing was made through the SEC EDGAR system according to SEC EDGAR.

Regulatory Reference

Section 3(c)(7) of the Investment Company Act provides an exemption from registration for certain privately offered funds sold only to qualified purchasers. The May 18 filing marks the formal indication of this exemption path for DNA Capital VC II LP according to SEC EDGAR.

Document Characteristics

The notice consists of a compact 10 KB filing. No additional exhibits or amendments appear in the indexed record. The submission stands as the initial public record of the fund’s regulatory posture according to SEC EDGAR.